Pulse BIOSCIENCES, Inc. (PLSE) intrinsic value & 10-year financials
Pulse BIOSCIENCES, Inc. (PLSE) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 10 fiscal years revenue shrank 29.5% a year to $350.0K, with an average return on invested capital of -565.8%.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $44.43
- Revenue (FY2025)
- $350.0K
- Revenue growth (10-yr CAGR)
- -29.5%
- ROIC (10-yr avg)
- -565.8%
- Free cash flow (FY2025)
- -$54.4M
PLSE 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $350.0K | -$72.8M | — | -$54.4M | -21982.6% | -1501.5% |
| FY2024 | $0 | -$53.6M | — | -$36.5M | — | -903.9% |
| FY2023 | $0 | -$42.2M | — | -$33.2M | — | -441.1% |
| FY2022 | $700.0K | -$58.5M | — | -$47.4M | -8293.9% | -425.8% |
| FY2021 | $1.4M | -$63.7M | — | -$54.5M | -4443.9% | -342.1% |
| FY2020 | $0 | -$49.9M | — | -$35.8M | — | -192.5% |
| FY2019 | — | -$47.0M | — | -$34.8M | — | -153.7% |
| FY2018 | — | -$37.5M | — | -$24.2M | — | — |
| FY2017 | — | -$25.6M | — | -$13.6M | — | — |
| FY2016 | — | -$9.5M | — | -$8.1M | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
PULSE BIOSCIENCES, INC. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
PULSE BIOSCIENCES, INC. has historically struggled to out-earn its cost of capital, averaging just -5.7% ROIC.
PULSE BIOSCIENCES, INC. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, PULSE BIOSCIENCES, INC. is modeled at -29.5% normalized earnings growth with a 5.1% bond-yield adjustment.